These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 9584206)
1. Differential uncoupling of A1 adenosine and D2 dopamine receptors by suramin and didemethylated suramin (NF037). Waldhoer M; Bofill-Cardona E; Milligan G; Freissmuth M; Nanoff C Mol Pharmacol; 1998 May; 53(5):808-18. PubMed ID: 9584206 [TBL] [Abstract][Full Text] [Related]
2. Biased inhibition by a suramin analogue of A1-adenosine receptor/G protein coupling in fused receptor/G protein tandems: the A1-adenosine receptor is predominantly coupled to Goalpha in human brain. Kudlacek O; Waldhoer M; Kassack MU; Nickel P; Salmi JI; Freissmuth M; Nanoff C Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):8-16. PubMed ID: 11862328 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of receptor/G protein coupling by suramin analogues. Beindl W; Mitterauer T; Hohenegger M; Ijzerman AP; Nanoff C; Freissmuth M Mol Pharmacol; 1996 Aug; 50(2):415-23. PubMed ID: 8700151 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins. Wise A; Sheehan M; Rees S; Lee M; Milligan G Biochemistry; 1999 Feb; 38(8):2272-8. PubMed ID: 10029519 [TBL] [Abstract][Full Text] [Related]
5. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study. Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542 [TBL] [Abstract][Full Text] [Related]
6. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells. Boundy VA; Pacheco MA; Guan W; Molinoff PB Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927 [TBL] [Abstract][Full Text] [Related]
7. Suramin analogues as subtype-selective G protein inhibitors. Freissmuth M; Boehm S; Beindl W; Nickel P; Ijzerman AP; Hohenegger M; Nanoff C Mol Pharmacol; 1996 Apr; 49(4):602-11. PubMed ID: 8609887 [TBL] [Abstract][Full Text] [Related]
8. Reconstitution of recombinant bovine A1 adenosine receptors in Sf9 cell membranes with recombinant G proteins of defined composition. Figler RA; Graber SG; Lindorfer MA; Yasuda H; Linden J; Garrison JC Mol Pharmacol; 1996 Dec; 50(6):1587-95. PubMed ID: 8967981 [TBL] [Abstract][Full Text] [Related]
9. Immunoprecipitation of A1 adenosine receptor-GTP-binding protein complexes in ciliary epithelial cells. Wax MB; Patil RV Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3057-63. PubMed ID: 8206723 [TBL] [Abstract][Full Text] [Related]
10. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723. Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544 [TBL] [Abstract][Full Text] [Related]
11. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain. Sóvágó J; Makkai B; Gulyás B; Hall H Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196 [TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes. Odagaki Y; Toyoshima R Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659 [TBL] [Abstract][Full Text] [Related]
13. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures. Siehler S; Nunn C; Zupanc GK; Hoyer D Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149 [TBL] [Abstract][Full Text] [Related]
14. G protein coupling and ligand selectivity of the D2L and D3 dopamine receptors. Lane JR; Powney B; Wise A; Rees S; Milligan G J Pharmacol Exp Ther; 2008 Apr; 325(1):319-30. PubMed ID: 18218829 [TBL] [Abstract][Full Text] [Related]
16. Reconstitution of bovine A1 adenosine receptors and G proteins in phospholipid vesicles: betagamma-subunit composition influences guanine nucleotide exchange and agonist binding. Figler RA; Lindorfer MA; Graber SG; Garrison JC; Linden J Biochemistry; 1997 Dec; 36(51):16288-99. PubMed ID: 9405064 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor. Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659 [TBL] [Abstract][Full Text] [Related]
18. Interactions between the dopamine D2 receptor and GTP-binding proteins. Plug MJ; Möller W; Dijk J Biochem Int; 1992 Oct; 28(1):21-9. PubMed ID: 1445393 [TBL] [Abstract][Full Text] [Related]
19. Suramin disrupts receptor-G protein coupling by blocking association of G protein alpha and betagamma subunits. Chung WC; Kermode JC J Pharmacol Exp Ther; 2005 Apr; 313(1):191-8. PubMed ID: 15626724 [TBL] [Abstract][Full Text] [Related]
20. Interaction of purified bovine brain A1-adenosine receptors with guanine nucleotide-binding proteins of human platelet membranes following reconstitution. Munshi R; Linden J Mol Pharmacol; 1990 Aug; 38(2):170-6. PubMed ID: 2117248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]